MedPath

Protocol for RCT of Posturing in Phacovitrectomy for Full Thickness Macular Hole (FTMH)

Not Applicable
Completed
Conditions
Full Thickness Macular Hole
Interventions
Behavioral: Face down posture
Registration Number
NCT01020760
Lead Sponsor
NHS Greater Glasgow and Clyde
Brief Summary

The purpose of this study is to determine the effect of postoperative posturing on the outcome of macular hole surgery. Current practice is divided; some individuals are advised to posture face-down for 10 days and others are advised that posturing is unnecessary. By evaluating the effect of posturing in a prospective randomised controlled trial the investigators hope to determine best practice, enabling surgeons and patients to make informed decisions regarding postoperative management.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  1. Patients having surgery for idiopathic full thickness macular hole
  2. Able and willing to posture face-down for 10 days postoperatively
  3. Agree to participate in the trial and able to give informed consent
Exclusion Criteria
  1. History of visual loss suggesting a duration of macular hole greater than 12 months
  2. Patients unable or unwilling to posture face-down for 10 days postoperatively
  3. History of trauma that may have been causative
  4. Age less than 16 years (in practice idiopathic macular hole is extremely rare in patients under 30 years).
  5. Previous vitrectomy surgery
  6. Additional retinal breaks occurring during surgery that necessitate post-operative posturing to prevent retinal detachment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Face down postureFace down posturePatients will undergo routine phacoemulsification, pars plana vitrectomy, ILM peel and gas fluid exchange with 14% C3F8. They will be advised to posture in the face down or prone position for 50 minutes per hour for seven days.
Primary Outcome Measures
NameTimeMethod
estimate variance and effect size order to inform power calculations for further studies.one year
Secondary Outcome Measures
NameTimeMethod
visual acuity and complicationsone year
estimate recruitment rate and establish protocol/procedureone year

Trial Locations

Locations (1)

Gartnavel General Hospital

🇬🇧

Glasgow, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath